dimecres, 26 de març del 2014

Study: Biosense Webster's force-sensing catheters lower AF recurrence




Patients with atrial fibrillation may be less likely to have recurring symptoms following ablation treatment with force-sending catheters from Johnson & Johnson subsidiary Biosense Webster, researchers say.





Study: Biosense Webster's force-sensing catheters lower AF recurrence



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/P1qnnF

Cap comentari:

Publica un comentari a l'entrada